00006-5331 WELIREG - CanMED: NDC

Product NDC:

00006-5331

Brand Name:

WELIREG

Generic Name:

Belzutifan

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: BELZUTIFAN

Strength: 40.0

Unit: mg/1

Packages:

Code: 00006-5331-01

Description: 90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01)

Effective Date: Aug. 13, 2021

Discontinued:

Code: 00006-5331-58

Description: 1 BOTTLE in 1 CARTON (0006-5331-58) / 90 TABLET, FILM COATED in 1 BOTTLE

Effective Date: June 21, 2023

Discontinued:

Code: 00006-5331-59

Description: 1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE

Effective Date: June 21, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Miscellaneous Agent

Minor Class:

HIF-2 alpha

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox